NFKB1 and diffuse large B-cell lymphoma: ABC-DLBCL is characterized by constitutive NF-κB activation mediated by the B-cell receptor (BCR) and Toll-like receptor (TLR) signaling pathways, and many oncogenic mutations within these pathways have been identified [111,112,113,114,115].